Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical

Published on:
March 15, 2021

BOSTON, USA – Alira Health, a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm as Vice President, Preclinical Development. Nikole joins the team with an expansive preclinical background serving the pharmaceutical industry and Clinical Research organizations (CRO) and is based out of Alira Health’s headquarters in Framingham, Massachusetts.

“It is an honor to have Nikole join Alira Health’s Product Development team to accelerate our business development efforts and manage our preclinical offerings, “ said Dr. Mitchell Sanders, Chief Scientific Officer. “Nikole’s wealth of experience in preclinical models, operations, and project management helps us expand our preclinical lab services in oncology, liver and metabolic disease, wound care, and surgery.

“I am excited to join the Alira Health team of dedicated professionals who work tirelessly to improve the healthcare industry and patient care,” said Nikole. “I look forward to working alongside our clients, developing, and improving technologies in the pre-clinical space, and further advancing patient care around the globe.”

Nikole brings over 20 years of preclinical experience in the CRO and pharmaceutical spaces. She is an experienced Vice President of Operations with a proven history of working in both large and small organizations.

Prior to Alira Health, Nikole worked with Woodland Pharmaceuticals LLC and has experience in oncology, NASH and metabolic diseases, PK/PD, Good Laboratory Practice (GLP), Data QC, and business development. She currently serves as a voting member of the Tufts University and Tufts Medical Center Institutional Animal Care and Use Committee.

Related news

News June 17, 2022
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
Crowdfunding Patient Centricity Research & Development
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
News April 5, 2022
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Clinical MedTech Patient Engagement Pharma Press Release Regulatory Research & Development
Publications December 10, 2021
Data Intelligence for Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Advanced Analytics Digital Health Pharma Research & Development
Events November 24, 2021
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Research & Development
Events October 20, 2021
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Best practices for European supply integrity distribution and management as highlighted by Alira Health’s internal experts.
EU Pharma Research & Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.